This Grand Round presented by Professor Gisli Jenkins will look into the road-map to precision medicine in pulmonary fibrosis.

Professor Gisli Jenkins Background

Professor Gisli Jenkins clinical focus is on interstitial lung disease and idiopathic pulmonary fibrosis in particular. Currently, he is the Familial Pulmonary Fibrosis lead for the Genomics England Clinical Interpretation Partnership in Respiratory Medicine and is Post Hospitalisation (PHOSP)-COVID study Fibrosis Working Group lead, also leading the UK interstitial Lung Disease consortium.

He is an NIHR research professor and holds the Margaret Turner-Warwick chair of thoracic medicine at Imperial College London. Professor Jenkins is the head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute.

He is the pulmonary fibrosis working group lead for the Genomics England Clinical Interpretation Partnership in Respiratory Medicine, the PHOSP-COVID study and the HEAL COVID platform study.